Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Healthcare Global Enterprises consolidated net profit declines 70.52% in the March 2026 quarter
Sales rise 11.46% to Rs 650.29 crore
Mankind Pharma profit jumps 30% on chronic therapy demand in Q4
Mankind Pharma announced a significant 30 percent profit increase for the fourth quarter. This growth was fueled by strong demand for chronic therapies and consumer healthcare products. The company's domestic formulations business is showing a revival. Improved sales execution and the successful integration of Bharat Serums and Vaccines contributed to this positive performance.
Bayer bets big on 'self-care' market to deepen India play
Global pharma major Bayer is significantly expanding its consumer healthcare presence in India, targeting the burgeoning self-care market estimated at ₹40,000 crore. The company is launching new products, including the antacid Alka-Seltzer, and aims to reach 100 million households within four years, positioning India as a top global market.
HCG opens new Bengaluru facility with Rs 129 crore investment
HealthCare Global Enterprises (HCG) has inaugurated a new 132-bed oncology facility in Bengaluru, marking its third hospital in the city with an investment of nearly Rs 129 crore. The advanced center utilizes cutting-edge MRI scanner machines for precise cancer treatment, aiming to manage even advanced metastatic cases. This expansion follows KKR's significant stake acquisition in HCG last year.
Amanta Healthcare standalone net profit declines 7.21% in the March 2026 quarter
Sales rise 6.84% to Rs 76.99 crore
GPT Healthcare rallies after Q4 PAT rises 13% YoY to Rs 15 crore
GPT Healthcare advanced 3.04% to Rs 142.30 after the company reported a 13.03% rise in consolidated net profit to Rs 14.57 crore in Q4 FY26, compared with Rs 12.89 crore in Q4 FY25.
Stocks to buy: Sagar Doshi suggests Varun Beverages, Max Healthcare, Page Industries shares to buy
The Indian stock market saw a marginal rise amid optimism over a potential nuclear deal with Iran. Nifty 50 advanced 0.11%, and the BSE Sensex increased by 0.17%. Despite this, Bank Nifty fell nearly 200 points, while analysts suggested specific stocks to buy.
Q4 Results LIVE Updates: IOC, Astral, Afcons react to earnings; BPCL, BEL report today
Q4 Results LIVE Updates: BPCL, Zydus Life, BEL, BLS International, Dhanuka Agri, Dredging Corp, Eureka Forbes, Hatsun Agro, Healthcare Global, J Kumar Infra, PI Industries, PNC Infratech, Prince Pipes, Safari Industries, RITES, Trident, Zee Entertainment, Shaily Engineering are among the other important numbers to track today along with result reactions from IOC, IGL, Afcons, Astral and many others. Stay tuned for all the live result reactions right here.
Pharmacy associations to skip strike, major medicine disruption unlikely
India's drug regulator is actively reviewing concerns from retail chemists about e-pharmacies. The All India Organisation of Chemists and Druggists had called for a strike. However, many pharmacy associations have stepped back, citing public interest and patient access. The regulator assures that issues are under consideration. Dialogue is seen as key to ensuring uninterrupted healthcare services for citizens.
Bank of America sees positive April data for Tenet Healthcare, neutral for HCA Healthcare - Investing.com India
Bank of America sees positive April data for Tenet Healthcare, neutral for HCA HealthcareInvesting.com India
GPT Healthcare Q4 PAT rises 13% YoY to Rs 15 crore
GPT Healthcare reported a 13.03% rise in consolidated net profit to Rs 14.57 crore in Q4 FY26, compared with Rs 12.89 crore in Q4 FY25.
Healthcare stock Cupid shows resilience against the stock market sell-off
Cupid share price rose 3.4% on May 18 after announcing strong Q4 FY26 results, with a 26% year-over-year income increase. The company plans aggressive growth, targeting ₹600 crore revenue in FY27 and expanding its FMCG distribution and product portfolio.